Home treatment for lymphedema — a painful cancer-related condition that causes tissues to swell — cuts costs and controls symptoms, a new study has found.
But unfortunately, insurers reimburse this type of therapy poorly, says Stanley Rockson, MD, senior author of the study and professor of cardiovascular medicine.
Rockson and his co-authors examined the impact on symptoms and costs of compression sleeves.
Based on the claims submitted to a national private health insurer from 2007 to 2013, they found that lymphedema patients who used the compression device cut their annual health-care cost of $62,190 to $50,000. “This is clearly a compelling argument for increased coverage of similar home-care devices to reduce costs,” Rockson says.
The research was published in PLOS ONE.